Vertex Announces Collaboration with Parion Sciences to Develop ENaC Inhitibors in CF, Pulmonary Diseases
June 04, 2015 at 16:02 PM EDT
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Parion Sciences today announced that the companies will collaborate to develop ...
